mrna-4157,pembrolizumab
merck,moderna
['mrna-4157', 'melanoma', 'pembro', 'moderna']
exciting new results on cancer vaccines by showing ~16% improvement in recurrence-free survival in high-risk melanoma patients using combination mrna-4157 with pembrolizumab compared to pembro alone #aacr23 
Postdoctoral Fellow at MIT